SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- Biosite Incorporated
(Nasdaq: BSTE) today announced that Kim Blickenstaff, chairman and chief
executive officer, and Ken Buechler, president and chief scientific officer,
will discuss the Company's operating environment, new and potential products
and the company's research and development activities at the 24th Annual JP
Morgan Healthcare Conference. Biosite's presentation will take place
Wednesday, January 11, 2006, at 8:00 a.m. Pacific. The conference is to be
held at the Westin St. Francis Hotel in San Francisco.
A link to the live audio webcast can be accessed through the Biosite
website, http://www.biosite.com. The Biosite presentation will be archived on the
website until February 2, 2006 in the Investor and Media section under Events
Calendar.
About Biosite Incorporated
Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis. The
Company's products contribute to improvements in medical care by aiding
physicians in the diagnosis of critical diseases and health conditions.
Biosite's Triage(R) rapid diagnostics are used in approximately 50 percent of
U.S. hospitals and in more than 50 international markets. Information on
Biosite can be found at http://www.biosite.com.
Biosite(R), Triage(R) and New Dimensions in Diagnosis(R) are registered
trademarks of Biosite Incorporated. The Company's logo is a trademark of
Biosite Incorporated.
SOURCE Biosite Incorporated
 back to top
Related links:
http://www.biosite.com
Company News On-Call:
http://www.prnewswire.com/comp/116737.html
CONTACT:
Nadine Padilla, Vice President, Corporate and
Investor Relations of Biosite Incorporated, +1-858-805-2820,
npadilla@biosite.com
|
